The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
555 jobs Number of planned job losses
Announcement Date
28 August 2008
Employment effect (start)
1 September 2008
Foreseen end date
31 December 2009
Description
The pharmaceutical group UCB, announced significant job losses in Belgium and in the world. In Belgium, both plants of Brussels and Braine-L'Alleud are concerned with anticipated job losses of 130 employees and 425 respectively. The job cuts are part of a worldwide restructuring process involving 2400 jobs losses and the creation of 400 new ones in other UCB plants.
Sources
28 August 2008: La Libre Belgique
Citation
Eurofound (2008), UCB Belgium, Internal restructuring in Belgium, factsheet number 67003, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67003.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
